Cargando…

Response to primary chemoradiotherapy of locally advanced oropharyngeal carcinoma is determined by the degree of cytotoxic T cell infiltration within tumor cell aggregates

BACKGROUND: Effective anti-tumor immune responses are mediated by T cells and require organized, spatially coordinated interactions within the tumor microenvironment (TME). Understanding coordinated T-cell-behavior and deciphering mechanisms of radiotherapy resistance mediated by tumor stem cells wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haist, Maximilian, Kaufmann, Justus, Kur, Ivan-Maximiliano, Zimmer, Stefanie, Grabbe, Stephan, Schmidberger, Heinz, Weigert, Andreas, Mayer, Arnulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175951/ https://www.ncbi.nlm.nih.gov/pubmed/37187729 http://dx.doi.org/10.3389/fimmu.2023.1070203

Ejemplares similares

Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study
por: Mayer, Arnulf, et al.
Publicado: (2020)

Using the R Package Spatstat to Assess Inhibitory Effects of Microregional Hypoxia on the Infiltration of Cancers of the Head and Neck Region by Cytotoxic T Lymphocytes
por: Kaufmann, Justus, et al.
Publicado: (2021)

Adjuvant chemoradiotherapy in elderly patients with head and neck cancer: a monoinstitutional, two-to-one pair-matching analysis
por: Mayer, Arnulf, et al.
Publicado: (2022)

The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment
por: Haist, Maximilian, et al.
Publicado: (2021)

Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters
por: Schmidberger, Heinz, et al.
Publicado: (2018)

Immunomodulatory Properties of Immune Checkpoint Inhibitors—More than Boosting T-Cell Responses?
por: Kuske, Michael, et al.
Publicado: (2022)

The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
por: Zahnreich, Sebastian, et al.
Publicado: (2023)

Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck
por: Mayer, Arnulf, et al.
Publicado: (2016)

Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly
por: Bostel, Tilman, et al.
Publicado: (2023)

Oxygen Deprivation Modulates EGFR and PD-L1 in Squamous Cell Carcinomas of the Head and Neck
por: Zahnreich, Sebastian, et al.
Publicado: (2021)

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer
por: HASEGAWA, MASAHIRO, et al.
Publicado: (2014)

Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond
por: Jung, Thomas, et al.
Publicado: (2021)

GLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva
por: Mayer, Arnulf, et al.
Publicado: (2014)

The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges
por: Stege, Henner, et al.
Publicado: (2021)

Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma
por: MAYER, ARNULF, et al.
Publicado: (2012)

Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma
por: Blatt, Sebastian, et al.
Publicado: (2022)

The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy
por: Young, Caroline A, et al.
Publicado: (2014)

Treatment outcomes of primary surgery versus chemoradiotherapy for T4 oropharyngeal cancers
por: Yen, Ching-Heng, et al.
Publicado: (2022)

Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial
por: von der Grün, Jens, et al.
Publicado: (2022)

The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma—A Retrospective, Real-World Cohort Study
por: Haist, Maximilian, et al.
Publicado: (2022)

Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma
por: Matlung, Sanne Evelien, et al.
Publicado: (2016)

Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors—A Retrospective, Real-World Cohort Study
por: Haist, Maximilian, et al.
Publicado: (2021)

Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?
por: Haist, Maximilian, et al.
Publicado: (2023)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Primary surgery versus chemoradiotherapy for advanced oropharyngeal cancers: a longitudinal population study
por: O’Connell, Daniel, et al.
Publicado: (2013)

Metastatic HPV‐related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment
por: Perri, Francesco, et al.
Publicado: (2017)

Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers
por: Lu, X. J. David, et al.
Publicado: (2022)

Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy
por: Ng, Shu-Hang, et al.
Publicado: (2013)

Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes
por: Bledsoe, Trevor J, et al.
Publicado: (2013)

Cell Surface Binding and Internalization of Aβ Modulated by Degree of Aggregation
por: Bateman, David A., et al.
Publicado: (2011)

Nanodrugs Targeting T Cells in Tumor Therapy
por: Haist, Maximilian, et al.
Publicado: (2022)

Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns
por: Huang, Yu-Han, et al.
Publicado: (2017)

Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
por: Oliva, Marc, et al.
Publicado: (2021)

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
por: Goedegebuure, R.S.A., et al.
Publicado: (2021)

Osteoradionecrosis of the hyoid bone after intra-arterial chemoradiotherapy for oropharyngeal cancer: MR imaging findings
por: Hatakeyama, Hiromitsu, et al.
Publicado: (2017)

Correlation of PD-L1 expression with toxicities and response in oropharyngeal cancers treated with definitive chemoradiotherapy
por: Srivastava, Smriti, et al.
Publicado: (2022)

Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8(+) T cells
por: Hladíková, Kamila, et al.
Publicado: (2019)

Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
por: Ward, M J, et al.
Publicado: (2014)

Fiber Aggregation in Nanocomposites: Aggregation Degree and Its Linear Relation with the Percolation Threshold
por: Cui, Baorang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bi66g441utf2r7isb0vftlom5k